Skip to main content

Table 2 Cox regression models predicting MACE according to glycemic status, HTN, and DLP

From: Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

 

HR (95% CI) for incident MACE

Category

Unadjusted model

Adjusted model 1

Adjusted model 2a

 NFG/−HTN/−DLP

1.0

1.0

1.0

 NFG/+HTN/+DLP

2.81 (1.92–4.11)

P = 0.000

2.59 (1.76–3.80)

P = 0.000

2.67 (1.79–3.98)

P = 0.000

 IFG/−HTN/−DLP

1.13 (0.64–2.02)

P = 0.657

1.07 (0.61–1.91)

P = 0.806

1.07 (0.60–1.90)

P = 0.817

 IFG/+HTN/+DLP

3.24 (2.10–5.01)

P = 0.000

2.89 (1.86–4.49)

P = 0.000

2.98 (1.89–4.71)

P = 0.000

 DM/−HTN/−DLP

4.65 (2.75–7.85)

P = 0.000

4.36 (2.58–7.37)

P = 0.000

4.51 (2.65–7.68)

P = 0.000

 DM/+HTN/+DLP

4.80 (3.24–7.11)

P = 0.000

4.46 (2.99–6.63)

P = 0.000

4.63 (3.03–7.08)

P = 0.000

 (IFG + DM)/−HTN/−DLP

1.97 (1.28–3.03)

P = 0.002

1.86 (1.21–2.86)

P = 0.005

1.85 (1.20–2.85)

P = 0.005

 (IFG + DM)/+HTN/+DLP

4.00 (2.83–5.67)

P = 0.000

3.63 (2.55–5.18)

P = 0.000

3.64 (2.50–5.31)

P = 0.000

Category

Unadjusted model

Adjusted model 1

Adjusted model 2b

 NFG/−HTN

1.0

1.0

1.0

 NFG/+ HTN

3.10 (2.35–4.10)

P = 0.000

2.56 (1.93–3.39)

P = 0.000

2.68 (2.01–3.56)

P = 0.000

 IFG/−HTN

1.23 (0.80–1.89)

P = 0.347

1.19 (0.78–1.83)

P = 0.422

1.20 (0.78–1.85)

P = 0.400

 IFG/+HTN

3.41 (2.44–4.77)

P = 0.000

2.77 (1.97–3.89)

P = 0.000

2.88 (2.04–4.07)

P = 0.000

 DM/−HTN

4.27 (2.99–6.12)

P = 0.000

4.06 (2.84–5.82)

P = 0.000

4.26 (2.95–6.16)

P = 0.000

 DM/+HTN

4.85 (3.51–6.72)

P = 0.000

4.13 (2.98–5.74)

P = 0.000

4.38 (3.10–6.19)

P = 0.000

 (IFG + DM)/−HTN

2.22 (1.62–3.04)

P = 0.000

2.14 (1.56–2.93)

P = 0.000

2.15 (1.57–2.95)

P = 0.000

 (IFG + DM)/+HTN

4.04 (3.06–5.35)

P = 0.000

3.35 (2.52–4.44)

P = 0.000

3.38 (2.51–4.54)

P = 0.000

Category

Unadjusted model

Adjusted model 1

Adjusted model 2c

 NFG/−DLP

1.0

1.0

1.0

 NFG/ + DLP

0.99 (0.75–1.31)

P = 0.953

1.10 (0.83–1.45)

P = 0.494

1.07 (0.81–1.42)

P = 0.627

 IFG/−DLP

1.18 (0.83–1.68)

P = 0.358

1.11 (0.78–1.57)

P = 0.576

1.08 (0.76–1.53)

P = 0.680

 IFG/+DLP

1.35 (0.96–1.89)

P = 0.084

1.42 (1.01–1.99)

P = 0.044

1.30 (0.92–1.84)

P = 0.138

 DM/−DLP

2.74 (1.91–3.94)

P = 0.000

2.52 (1.75–3.62)

P = 0.000

2.35 (1.62–3.41)

P = 0.000

 DM/+ DLP

2.64 (1.98–3.51)

P = 0.000

2.70 (2.03–3.61)

P = 0.000

2.48 (1.83–3.35)

P = 0.000

 (IFG + DM)/−DLP

1.63 (1.23–2.15)

P = 0.001

1.51 (1.14–2.00)

P = 0.004

1.44 (1.08–1.91)

P = 0.012

 (IFG + DM)/+DLP

1.93 (1.51–2.48)

P = 0.000

2.01 (1.56–2.58)

P = 0.000

1.80 (1.39–2.34)

P = 0.000

  1. Model 1: adjusted for age + sex. Model 2a: adjusted for age + sex + BMI + smoking (Never as reference). Model 2b: adjusted for age + sex + BMI + smoking (Never as reference) + DLP. Model 2c: adjusted for age + sex + BMI + smoking (Never as reference) + HTN. NFG Normal fasting glucose, IFG impaired fasting glucose, HTN Hypertension, DLP Dyslipidemia